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Chronic Obstructive Pulmonary Disease and Weaning of Difficult-to-Wean 
Patients from Mechanical Ventilation: Randomized Prospective Study
Aim To compare T-tube and pressure support ventilation (PSV) as two 
methods of mechanical ventilation weaning of patients with chronic ob-
structive pulmonary disease (COPD) after failed extubation.
Methods A prospective randomized trial carried out at the multidis-
ciplinary intensive care unit (ICU) over 2 years included 136 patients 
with COPD who required mechanical ventilation longer than 24 hours. 
The patients who could be weaned from mechanical ventilation were 
randomized to either a T-tube or PSV 2-hour spontaneous breathing 
trial. The patients in whom 2-hour trial was successful were extubated 
and excluded from further research. Patients in whom 2-hour trial failed 
had mechanical ventilation reinstated and underwent the same weaning 
procedure after 24 hours in case they fulfilled the weaning criteria. The 
weaning outcome was assessed according to the following parameters: 
extubation success, mechanical ventilation duration, time spent in ICU, 
reintubation rate, and mortality rate.
Results Two-hour trial failed in 31 patients in T-tube and 32 patients in 
PSV group, of whom 17 and 23, respectively, were successfully extubated 
(P<0.001, χ2 test). Mechanical ventilation lasted significantly longer in T-
tube than in PSV group (187 hours vs 163 hours, respectively, P<0.001, 
Mann-Whitney test). Also, patients in T-tube group spent significantly 
more time in ICU than patients in PVS group (241 hours [interquartile 
range 211-268] vs 210 hours [211-268], respectively, P<0.001, Mann-
Whitney test). Reintubation was required in 8 and 6 patients in T-tube 
and PVS group, respectively, and death occurred in 4 and 2 patients, re-
spectively, during ICU stay.
Conclusion Patients with COPD who failed the 2-hour spontaneous 
breathing trial had more favorable outcome when PVS rather than T-
tube method was used for weaning from mechanical ventilation.
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Chronic obstructive pulmonary disease 
(COPD) is a disease with an increasing preva-
lence and mortality worldwide (1). Acute respi-
ratory failure (ARF) due to COPD is becoming 
an ever-larger medical and economic problem 
not only in developed, but also in developing 
countries (2). The main characteristic of COPD 
is an airflow limitation that is not fully reversible, 
but usually progressive and associated with an ab-
normal bronchoalveolar inflammatory response 
to noxious particles or gases (3). COPD encom-
passes chronic bronchitis and emphysema. Se-
vere form of the disease usually causes a state of 
chronic respiratory muscle compromise because 
of the incomplete alveolar emptying at the end 
of expiration leading to dynamic hyperinflation, 
intrinsic positive end-expiratory pressure, flat-
tened diaphragm, recruitment of accessory respi-
ratory muscles, and changes in the shape of the 
rib cage (4). Therapeutic management of COPD 
includes administration of antibiotics for those 
with infection, systemic corticosteroids, β2 ago-
nists, oxygen, physiotherapy, mechanical ventila-
tion (MV), and lung transplant (5).
Mechanical ventilation is often life-saving 
when patients with COPD experience acute re-
spiratory compromise (6,7), but it also has its 
risks. There are adverse effects caused by PEEPi, 
which need to be kept in mind, including baro-
trauma risk, hemodynamic compromise, over-
load of inspiratory muscles, and weaning failure 
(8).
Weaning from MV is a process where MV 
is gradually withdrawn and the patient resumes 
spontaneous breathing (9). The major factor in 
successful weaning is the resolution of precipitat-
ing illness and a stable low requirement for oxy-
gen (10). However, neither laboratory nor clin-
ical parameters have been defined on when to 
begin with the weaning procedure. If the wean-
ing procedure is started early, it can often lead 
to cardiorespiratory failure. On the other hand, 
if it is started too late, it can be unsuccessful be-
cause of respiratory muscle weakness caused by 
deconditioning and disrupted breathing regula-
tion (11).
Evaluation of the MV outcome and under-
standing of the weaning procedure and extuba-
tion have a significant clinical importance (12). 
It has been estimated that the weaning phase ac-
counts for approximately 40% of the time that 
the patient spends on a mechanical ventilator. In 
patients with COPD this phase may account for 
as much as 59% of that time (13).
Overall, the weaning procedures are unsuc-
cessful in around 20% of the cases (14), where-
as the first weaning attempt in patients with 
COPD is unsuccessful in over 50% of the cases 
(15). Unsuccessful weaning of COPD patients 
from mechanical ventilator is predictive of poor 
outcome, including mortality, which is 2.6% 
only in patients successfully weaned from MV 
and as high as 27% in those who require reintu-
bation (16).
The best weaning procedure has not yet been 
established. There are four basic techniques as fol-
lows: spontaneous breathing using T-piece, pres-
sure support ventilation (PSV), synchronized in-
termittent mandatory ventilation (SIMV), and 
biphasic positive airway pressure (BiPAP). Dif-
ferent weaning procedures have different reintu-
bation statistics. In patients with expiratory flow 
limitation, which is common in COPD, these 
modes may lead to an increased dynamic hyper-
inflation and PEEPi. The deterioration of respi-
ratory mechanics increases the elastic work of 
breathing and may cause weaning failure (17).
Over the past decade, non-invasive positive 
pressure ventilation (NPPV) in cases of acute ex-
acerbations of COPD has gained in popularity. 
However, in hospital settings, patients with mild-
er COPD exacerbations have not been shown to 
benefit from the addition of NPPV to the con-
ventional therapy (18). Moreover, NPPV had a 
high rate of failure in COPD patients with ad-
vanced hypercapnic acute respiratory failure, al-
though it did provide some advantages in com-
parison with conventional MV (19). The choice 
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between NPPV and invasive MV depends upon 
the severity of illness, the rapidity of response, co-
existing diseases, and capacity of the medical en-
vironment. NPPV is used in the treatment of 
mild or simple conditions, whereas invasive MV 
is usually required in case of a more complex or 
severe disease. MV settings should be adjusted so 
to ensure controlled hypoventilation, longer ex-
piratory time, and titrated PEEP-e to avoid dy-
namic hyperinflation and its consequences (20).
None of the many clinical trails was able to 
establish whether T-tube or PSV method was 
superior in weaning patients with COPD from 
MV. Therefore, we decided to compare these 
two weaning methods of patients with COPD 
in whom extubation failed after a 2-hour sponta-
neous breathing trial.
Patients and methods
Patients
The study included 136 adult patients with 
COPD requiring MV longer than 24 hours who 
were admitted to a multidisciplinary intensive 
care unit (ICU) at Dr Josip Benčević General 
Hospital in Slavonski Brod between April 2004 
and April 2006. The diagnosis of COPD was 
confirmed on the basis of medical history, phys-
ical examination, chest radiography, and recent 
pulmonary function tests (airflow obstruction, 
hyperinflation, and air trapping). Only patients 
with COPD who had exacerbation of dyspnea 
that lasted <2 weeks, alternating rhythm of respi-
ration, and abdominal paradox as signs of respi-
ratory muscle dysfunction were included in the 
study. Exclusion criteria were absence of COPD, 
age <18 years, tracheotomy, MV duration short-
er than 24 hours, use of MV on admission to the 
ICU or transfer to some other ICU for treat-
ment continuation, death or weaning from MV 
was discontinued because of another associated 
disorder, central nerve system disorders unrelat-
ed to hypercapnic encephalopathy or hypoxemia, 
cardiac arrest within 5 days, and being scheduled 
for organ donation.
The patients were randomly assigned to one 
of the two weaning methods by use of two closed, 
non-transparent, identically looking envelops, 
each containing information on one of the wean-
ing methods investigated. After a patient was in-
cluded in the study, a third party not involved 
in the study was asked to choose one of the en-
velopes. Depending on the information in the 
chosen envelope, the patient was allocated to un-
dergo weaning either by T-piece or by PSV. The 
following data were collected: Acute Physiologic 
And Chronic Health Evaluation (APACHE II) 
score (21), sex, age, and parameters of weaning 
from MV, including ventilation time before the 
first spontaneous breathing trial and failure time 
during the first spontaneous breathing trial.
The study was carried out in line with ethical 
principles and approved by the Hospital Ethics 
Committee.
Weaning from mechanical ventilation procedure
The procedure of weaning from MV began by 
an assessment and objective measurement of 
the following respiratory mechanical and bio-
chemical parameters: improvement of the un-
derlying cause of respiratory failure (assessed by 
APACHE II scoring), spontaneous respiratory 
rate (RR)<25/min, spontaneous respiratory vol-
ume (Vt)>0.005 L/kg of body weight, maximal 
spontaneous inspiratory effort (PImax)≤25 cm 
H2O, heart rate <140/min, body temperature 
<38.5°C, hemoglobin >100 g/L, partial arteri-
al oxygen pressure (PaO2)>60 mm Hg with in-
spired oxygen fraction (FiO2)≤0.4, extrinsic posi-
tive end-expiratory pressure (PEEP)<5 cm H2O, 
no need for vasoactive and/or inotropic support, 
PaO2/FiO2 ratio >200, and RR/Vt ratio <100.
In patients who met these criteria the wean-
ing procedure started by a 5-minute spontane-
ous breathing trial. If this trial was successful, a 2-
hour spontaneous breathing trial was performed. 
An initial 5-minute trial was considered success-
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ful if RR was between 8 and 25 breaths/min, Vt 
>5 mL/kg, and RR/Vt ratio <100.
The 2-hour spontaneous breathing trial was 
performed with either T-tube or PSV, with ini-
tial positive pressure of 18 cm H2O. Criteria for a 
successful 2-hour trial were the same as for the 5-
minute trial. Patients in whom the 2-hour spon-
taneous breathing trial was successful were then 
extubated and excluded from further research.
If one or more signs of poor procedure tol-
erance were observed during the 2-hour tri-
al, the patient was considered difficult-to-wean 
and returned to the MV. The ventilator settings 
were adjusted to provide full support of ventila-
tion and allow muscle rest. In such patients, the 
same procedure of weaning was repeated after 24 
hours, if permitted by the patient’s clinical condi-
tion, following the same protocol. Signs of a low 
2-hour trial tolerance, which were used as the cri-
teria for termination of the trial, included spon-
taneous respiratory rate >25/min, SatO2<90%, 
FiO2≤0.4, heart rate >140/min (or more than 
20% change from the initial heart rate), systol-
ic blood pressure >200 mm Hg or <80 mm Hg, 
PaO2≤60 mm Hg, pH≤7.30, and restlessness.
For patients who were weaned by means of 
PSV, initial positive pressure support was 18 cm 
H2O. This support was then lowered by 2-4 cm 
H2O based on the parameters of pulmonary me-
chanics, biochemistry, and circulation. Patients 
were extubated at pressure support of 5 cm H2O, 
which was necessary to overcome increased air-
way resistance (reduced airway diameter due to 
an endotracheal tube).
Weaning procedure was considered success-
ful when the unassisted spontaneous breathing 
was sustained for 48 consecutive hours without 
respiratory distress, with pH>7.35 and PaO2>60 
mm Hg in a patient breathing through a mask 
at FiO2≤0.4. The weaning outcome was consid-
ered a failure when the patient needed continu-
ing mechanical ventilator support for >7 days af-
ter weaning assessment or when death occurred 
before the ICU discharge. Initiation of MV sup-
port within 48 hours of liberation from MV was 
also considered to be a failure. Criteria for rein-
tubation were a lack of improvement in arterial 
blood gases within 2 hours after MV discontin-
uation, worsening of respiratory distress, dete-
rioration of the neurological status, including 
psychomotor agitation requiring sedation, and 
life-threatening cardiovascular alterations.
Assessment methods
Mechanical ventilation was administered with 
Evita Drager dura 2 respirators (Dräger, Lubeck, 
Germany) or with Puritan Bennet 7200 respira-
tors (Puritan Bennet, Carlsbad, CA, USA). Pa-
rameters of pulmonary mechanics were direct-
ly measured on the respirator. The tidal volume 
and respiratory rate of spontaneous breathing pa-
tients were measured with a spirometer (Ohm-
eda Biox, Louisville, CO, USA), and maximal 
inspiratory pressure was measured with manom-
eter (Ohmeda Biox). Arterial blood gases analy-
sis was performed on a Ciba Corning Blood Gas 
Machine (Ciba Corning, Halsted, UK). Car-
dio-respiratory functions including systolic and 
diastolic blood pressure, heart rate, and end-tid-
al CO2 were continuously monitored on Datex 
monitors (Datex Ohmeda, Helsinki, Finland), 
and ventilation and oxygenation were monitored 
on Datex Engstrom AS3 and CS3 Compact 
Monitors (Datex Ohmeda).
Statistical analysis
Based on the power analysis, the study aimed to 
recruit 136 patients in order to have 70% power 
of detecting a clinically significant difference in 
the proportion of patients experiencing 2-hour 
trial failure at the 5% level of significance, with 
the assumption that 50% of the T-tube 2-hour 
trial failure group would fulfill the criteria for ex-
tubation failure and that a reduction to 20% in 
the PSV 2-hour trial failure group would be clin-
ically relevant.
Qualitative and numerical data were present-
ed as median, minimum, maximum, interquartile 
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range (IQR), and centile distribution. Frequency 
tables were used to present qualitative data. Two 
independent qualitative variables in contingen-
cy tables were compared with χ2 test. Fisher ex-
act test was used for small samples. Mann-Whit-
ney test was used to compare two independent 
groups of numerical data. Normality of distribu-
tion was tested with the Kolmogorow-Smirnov 
test. P<0.01 was considered statistically signifi-
cant. Statistical analysis was performed with Sta-
tistical Package for Social Sciences 9.0 for Win-
dows (Standard version, SPSS Inc., Chicago, IL, 
USA).
Results
Out of 136 patients with COPD included in the 
trial, 66 were allocated for weaning from MV us-
ing 2-hour T-tube trial and 70 were allocated for 
2-hour PSV trial (Figure 1). The weaning was 
unsuccessful in 31 (47%) patients from T-tube 
group and 32 (46%) from PSV group. Of pa-
tients in whom weaning failed, 17 (56%) in the 
T-tube group and 23 (72%) in the PSV group 
were successfully extubated.
The two groups of patients did not signifi-
cantly differ in age, sex distribution, APACHE II 
score, median ventilation time before spontane-
ous breathing trial, or median failure time during 
the first spontaneous breathing trial (Table 1).
There was no significant difference in the me-
dian respiratory rate and median tidal volume 
during spontaneous breathing trial between the 
patients in the T-tube group and those in the 
PSV group (Table 2). However, median maxi-
mal spontaneous breathing effort was significant-
ly higher in the T-tube group than in the PSV 
group, as opposed to median PaO2/FiO2 ratio, 
which was significantly lower in the T-tube than 
in PSV group (Table 2). Median RR/Vt ratio did 
not differ between the groups.
The outcome of weaning from MV was as-
sessed on the basis of duration of weaning, to-
tal MV duration, time the patient spent in ICU, 
Figure 1. Flow of patients through the study. *Abbreviations: ICU – intensive 
care unit, MV – mechanical ventilation, COPD – chronic obstructive pulmonary 
disease, PSV – pressure support ventilation.†Patients excluded due to: non-
COPD (n = 660), COPD with MV<24h (n = 10), COPD with tracheotomy (n = 1).
Table 1. Demographic and clinical characteristics of patients 
with chronic obstructive pulmonary disease undergoing wean-
ing from mechanical ventilation by use of either T-tube or pres-
sure support ventilation*
Median (IQR)
Patient characteristics T-tube (n = 31) PSV (n = 32) P†
No. (%) of men  17 (56.0)  19 (60.0) 0.411
Age (years)  59 (41-71)  57 (32-68) 0.529
APACHE II score  29 (23-31)  31 (23-34) 0.424
Ventilation time before spontaneous 
 breathing trial (hours) 124 (94-151) 120 (88-139) 0.534
Failure time during first spontaneous 
 breathing trial (minutes)  75 (50-98)  88 (64-112) 0.060
*Abbreviations: IQR – interquartile range, PSV – pressure support ventilation, 
APACHE – Acute Physiologic and Chronic Health Evaluation.
†Mann-Whitney test.
Table 2. Parameters of T-tube or pressure support ventilation in 
weaning difficult-to-wean patients with chronic obstructive pul-
monary disease from mechanical ventilation*
Median (IQR)
Parameter T-tube (n = 31) PSV (n = 32) P†
Spontaneous respiratory rate 
 (per min)  22 (19-25)  21 (14-25) 0.880
Spontaneous breathing 
 volume (mL) 420 (390-478) 450 (410-515) 0.540
Maximal spontaneous breathing 
 effort (cm H2O)  -32 (-40 to -27)  -29 (-36 to -27) 0.003
Pao2/FiO2 ratio 220 (211-252) 230 (220-272) 0.070
RR/Vt ratio (L/breath/min)  74 (63-80)  72 (59-88) 0.810
*Abbreviations: IQR – interquartile range, PSV – pressure support ventilation, PaO2 
– partial arterial oxygen pressure, FiO2 – inspiratory oxygen fraction, RR – spontane-
ous respiratory rate, Vt – spontaneous breathing volume.
†Mann-Whitney test.
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number of successfully vs unsuccessfully extubat-
ed patients, number of patients requiring reintu-
bation, and ICU mortality rate. Median weaning 
time from MV and median MV duration were 
both significantly longer in T-tube group than 
in PSV group (Table 3). Weaning time account-
ed for 43% of the total MV duration in T-tube 
group and for 36% in PSV group. Patients in T-
tube group also spent significantly more time in 
ICU than did the patients in PSV group. Extu-
bation was successful in 17 patients in T-tube 
and in 23 patients in PSV group, while it was un-
successful in 14 patients in T-tube and in 9 pa-
tients in PSV group (Table 3). Eight patients in 
T-tube and 6 in PSV group needed reintuba-
tion. Four patients in T-tube group and 2 in PSV 
group died. Two patients in each group died of 
septic shock, one patient in T-tube group died of 
peritonitis and one of coagulopathy.
Discussion
The major finding of our study was that both 
spontaneous breathing using T-tube and PSV 
are suitable methods for successful weaning of 
patients with COPD from MV, although PSV 
proved to be more successful according to the 
measured parameters. To be able to adequately 
analyze the data, we first had to standardize the 
weaning procedures, which was accomplished us-
ing a 5-minute and 2-hour spontaneous breath-
ing trial. The failure time during first spontane-
ous breathing trial was not predictive of failure 
after T-tube or PSV weaning because the study 
insisted on the 2-hour trial. In patients who 
failed the 2-hour trial, the procedure was repeat-
ed after 24-hour if permitted by the patient’s 
clinical condition, again following the same pro-
tocol. This was probably the reason why there 
was no difference between groups.
Kollef et al (22) compared the protocol 
method with the weaning procedure dictated by 
medical staff and concluded that the art and ap-
plication of MV had influenced the weaning pro-
cedure more than the ventilation method itself. 
Furthermore, Smyrnios et al (23) found that MV 
weaning management protocol implemented as a 
hospital-wide quality improvement program lead 
to large reductions in the duration of MV, length 
of stay, and hospital costs. For this reason, we de-
cided to apply and follow strictly defined proto-
cols for both of the weaning methods investigat-
ed in our study. We also always avoided clinical 
experience-based weaning from MV and extuba-
tion.
There are different methods for weaning 
from MV. Esteban et al (17) compared 4 meth-
ods of weaning from MV, including intermittent 
mandatory ventilation, PSV, multiple, and sin-
gle spontaneous breathing trial with T-tube. The 
median time of weaning with intermittent man-
datory ventilation and PSV was 5 and 4 days, re-
spectively. The single and multiple trials with 
T-tube proved to be most successful, with the 
median of 3 days. Brochard et al (24) compared 
synchronized intermittent mandatory ventila-
tion, PSV, and T-tube weaning method, and 
found that PSV was superior to the other two 
methods of weaning from mechanical ventila-
tion. Their finding is in accordance with our re-
sults, although we have to take into account the 
differences in the inclusion criteria, because there 
were patients with non-COPD conditions re-
cruited in their study.
Table 3. Effects of T-tube and pressure support ventilation 
method for weaning difficult-to-wean patients with chronic ob-
structive pulmonary disease from mechanical ventilation on 
weaning outcomes
No. (%) of patients
Weaning outcomes T-tube (n = 31) PSV* (n = 32) P
MV weaning duration 
 (median, IQR, hours)  63 (51-69)  43 (35-49) <0.001†
MV total duration 
 (median, IQR, hours) 187 (143-222) 163 (113-203) <0.001†
Time spent in ICU 
 (median, IQR, hours) 241 (211-268) 210 (186-241) <0.001†
Successful extubation  17 (56.0)  23 (72.0) <0.001‡
Need for reintubation§   8 (24.0)   6 (16.0) –
ICU mortality rate§   4 (12.0)   2 (8.0) –
*Abbreviations: MV – mechanical ventilation, PSV – pressure support ventilation, IQR 
– interquartile range, ICU – intensive care unit.
†Mann-Whitney test.
‡χ2 test.
§Not analyzed due to small number of patients.
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We compared the outcomes of T-tube and 
PSV weaning procedures and found that PSV 
produced more favorable results with respect to 
MV duration. Reduced total MV duration time 
with PVS weaning method also reduced the to-
tal time spent in ICU. The percentage of total 
MV time spent on weaning itself was lower in 
the PSV than T-tube group, and in both groups, 
it accounted for less than 50% of the total MV 
duration as opposed to 59% of total MV time 
reported by Kuhlen et al (13). In our study ex-
tubation was successful in more patients in the 
PSV than T-tube group. Petrof et al (15) report-
ed extubation to be successful in half of the pa-
tients with COPD included in their study. These 
results suggest that weaning of patients with 
COPD from MV presents a significant problem. 
Taking into consideration the increasing costs of 
this treatment, further research should be con-
ducted to find the ways to reduce the weaning 
time and total MV duration time, as well as to in-
crease the extubation success rates. Reintubation 
was necessary in several patients in both groups, 
and a few patients died in both groups. We could 
not compare the reintubation and death rates in 
two groups, because the number of these patients 
was too small.
Our study had some limitations. Due to the 
small sample size, parameters such as ICU mor-
tality and need for reintubation could not be 
statistically analyzed. Also, patients were mon-
itored only during ICU stay, and no data were 
collected after patients were discharged from 
the ICU.
In conclusion, based on the shorter time 
needed for weaning from MV, total MV du-
ration, median time spent in ICU, and lower 
proportion of successfully extubated patients, 
PSV was shown to be more suitable than T-
tube weaning method for difficult-to-wean pa-
tients with COPD. Further research should col-
lect data for such patients on a hospital, regional, 
or state level to ensure large sample size, which 
would allow drawing more reliable conclusions. 
The data on such patients should also be collect-
ed from the moment COPD was diagnosed, in-
cluding when MV was first administered. Fur-
thermore, 1-year and 3-year mortality rates 
should be determined to gain full insight into the 
problem of MV and weaning of patients with 
COPD from MV.
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